Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenue $ 0 $ 2,550
Costs and Operating Expenses    
Cost of revenue, excluding depreciation 0 670
Research and development expenses, excluding depreciation 246,245 142,862
Selling, general and administrative expenses, excluding depreciation 194,736 51,611
Depreciation 8,921 7,125
Total costs and operating expenses 449,902 202,268
Loss from operations (449,902) (199,718)
Other (expense) income    
Interest income (expense) 103 (10,479)
Gain on fair value change in contingent earnout shares liability 104,446 115,375
(Loss) gain on fair value change in private placement warrants liability (1,639) 3,132
Gain on extinguishment of debt 0 5,045
Other income (expense), net 224 (39)
Loss before income taxes (346,768) (86,684)
Provision for income taxes 0 (2)
Net loss and comprehensive loss $ (346,768) $ (86,686)
Per Share Data:    
Net loss per share, basic (in dollars per share) $ (1.52) $ (0.79)
Net loss per share, diluted (in dollars per share) $ (1.52) $ (0.79)
Weighted-average shares outstanding, basic (in shares) 227,909 110,378
Weighted-average shares outstanding, diluted (in shares) 227,909 110,378